Rybelsus is semaglutide in tablet form for adults with type 2 diabetes, and Novo Nordisk is now replacing it with the Ozempic pill. NovoCare's Rybelsus page opens with exactly that: Rybelsus is being replaced by Ozempic pill, and your health care provider will guide you through the change.1
So the honest answer to "should I take Rybelsus" in October 2026 is mostly a question about the pill that follows it.
What Rybelsus is approved to do
Novo lists two uses for the 7 and 14 mg Rybelsus tablets, the same two it lists for the 4 and 9 mg Ozempic tablets:1
- with diet and exercise, to improve blood sugar in adults with type 2 diabetes;
- to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes at high risk of them.
That second line is newer than most pages about Rybelsus, which still describe it as a blood sugar drug only.
Moving from Rybelsus to the Ozempic pill
Novo pairs the tablets like this and says the Ozempic tablets work similarly, with the same efficacy and safety as Rybelsus:2
| Rybelsus tablet | Ozempic pill tablet |
|---|---|
| 3 mg | 1.5 mg |
| 7 mg | 4 mg |
| 14 mg | 9 mg |
The numbers are different because the formulation is different, not because the dose is lower. Which strength you move to is your prescriber's decision; the pairing above is Novo's, not ours.
Three things Novo states plainly about the switch:2
- It needs a new prescription. A pharmacy cannot swap one for the other on its own.
- Coverage carries over. The Ozempic pill gets the same coverage as Rybelsus, and with insurance your cost depends on your plan.
- So does a savings offer. A patient already using a Rybelsus offer keeps the discount on Ozempic without signing up again. The details are in the Rybelsus coupon guide.
Three semaglutide pills, and where Rybelsus fits
Novo now sells three tablets of the same molecule. They are separate products with separate labels:
| Pill | Tablet strengths | Used for | At NovoCare Pharmacy self-pay |
|---|---|---|---|
| Rybelsus | 3, 7, 14 mg2 | Type 2 diabetes1 | Not listed |
| Ozempic pill | 1.5, 4, 9 mg2 | Type 2 diabetes1 | From $149 a month3 |
| Wegovy pill | 1.5, 4, 9, 25 mg4 | Weight loss and keeping it off5 | $149 to $299 a month by dose4 |
The Ozempic pill and the Wegovy pill share three strengths but carry different labels. Rybelsus shares a strength with neither, which is why a switch is a new prescription and not a relabel.
What it costs without insurance
NovoCare Pharmacy, Novo's own cash counter, does not list Rybelsus. It lists the Ozempic pill, with self-pay options starting at $149 a month for people whose commercial plan does not cover it or who have no insurance, priced by dose.3 A self-pay fill is processed outside your insurance: it does not count toward a deductible or an out-of-pocket maximum.3
The savings offer is the other route, for commercially insured patients: as little as $25 a month, with the saving capped at $100 a month, and government beneficiaries excluded.3 On Medicare, Part D coverage for type 2 diabetes is the first thing to check.
If you are paying out of pocket and are not tied to Novo's pharmacy, these are the programs we track that sell an oral semaglutide, cheapest first at today's prices:
Rybelsus and weight loss
Rybelsus is labelled for type 2 diabetes, not for weight. Using it for weight would be off-label and a prescriber's call. The semaglutide tablet Novo labels for weight is the Wegovy pill, used with a reduced calorie diet and more activity to help adults with obesity, or with excess weight and a weight-related condition, lose weight and keep it off.5 More in the Wegovy pill guide.
The verdict
Rybelsus still treats what it always treated, but Novo is moving its patients to the Ozempic pill. If you are insured, ask your prescriber about the new prescription; Novo says coverage and any savings offer follow you. If you pay cash, Rybelsus has no price at Novo's own pharmacy, and the Ozempic pill starts at $149 a month there, so compare that with the board above before you buy.
